New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk

BACKGROUND: The use of estrogen plus progestin therapy increases both breast cancer incidence and breast tenderness. Whether breast tenderness during estrogen plus progestin therapy is associated with breast cancer risk is uncertain. METHODS: We analyzed data from the Women’s Health Initiative Estro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Crandall, Carolyn J., Aragaki, Aaron K., Chlebowski, Rowan T., McTiernan, Anne, Anderson, Garnet, Hendrix, Susan L., Cochrane, Barbara B., Langer, Robert D., Kuller, Lewis H., Cauley, Jane A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670683/
https://ncbi.nlm.nih.gov/pubmed/19822825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2009.303
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items